Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
نویسندگان
چکیده
منابع مشابه
Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy.
PURPOSE The aim of the study was to investigate the vascular and stromal architecture of preclinical tumor models and patient tumor specimens from malignancies with known clinical outcomes to VEGFi treatment, to gain insight into potential determinants of intrinsic sensitivity and resistance. EXPERIMENTAL DESIGN The tumor stroma architecture of preclinical and clinical tumor samples were anal...
متن کامل1 Tumour - stromal architecture can define the intrinsic tumour response to VEGF - targeted therapy
Running title: Tumour-stromal phenotypes define VEGF sensitivity Conflict of interest statement: All authors are current or former AstraZeneca employees and shareholders. There are no other conflicts of interest to disclose. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Translational Relevance VEGF pathway inhibitors (VEGFi) are approved f...
متن کاملSarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages
In gastrointestinal stromal tumor (GIST), the most common human sarcoma, tumor-associated macrophages (TAMs) have been found to be abundant and surprisingly M1-like, exhibiting antitumoral activities. However, TAMs switch to M2-like during the course of imatinib therapy, but upon drug resistance TAMs revert to M1-like. Therefore, the oncologic efficacy of TAM depletion may depend on tumor type ...
متن کاملTumor refractoriness to anti-VEGF therapy
Vascular endothelial growth factor (VEGF) has been identified as the most potent cytokine involved in tumor angiogenesis and metastasis formation. Clinical results of anti-angiogenic therapies targeting VEGF and its receptors are very modest, resulting in a moderate improvement of overall survival. The clinical outcome is associated with the development of resistance and the increased risk of i...
متن کاملTherapy-activated stromal cells can dictate tumor fate
In this issue of JEM, Chan et al. describe a novel way by which an investigational form of chemotherapy known as low-dose metronomic chemotherapy can inhibit tumor growth, which also has therapeutic implications for targeting tumor-initiating cells (TICs), the tumor stroma, and chemokine receptors, as well as invasion and metastasis.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2013
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-13-1637